OpenResearchAlpha

bioRxiv · 20 Nov 2026

Multiple isoforms of cancer stemness regulator NanogP8 in clinical prostate cancer specimens and their unique biochemical and oncogenic properties

Bigang Liu, Rahul Kumar, Xiaozhuo LIU, Shan Wu, Jianjun Shen, Qiuhui Li, Xin Chen, Kiera Rycaj, Jie Xiong, Ruifang Liu, Rashid Mehmood, Collene Jeter, Dean G. Tangh-index 71

0
Citations
no database records one yet
0
Citations in 2026
so far
71
Leading author's h-index
Dean G. Tang, in QAI's scholar index
0
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

The pluripotency regulator Nanog (NANOG, for human protein) has been reported to be overexpressed in cancers and in cancer stem cells (CSCs). We have previously shown that NanogP8, encoded by one of the expressed Nanog pseudogenes, is the predominant transcript expressed in several cancers including prostate cancer (PCa). We have also demonstrated that NanogP8 is functionally important in tumorigenesis as its loss impairs tumor regeneration and growth while inducible expression of NanogP8 is sufficient to reprogram androgen-dependent PCa to an androgen-independent and castration-resistant state. In the current study, we combined RT-PCR, subcloning and sequencing to systematically analyze the open reading frame sequences of Nanog and NanogP8 mRNA transcripts in treatment-naïve clinical human PCa (HPCa) specimens. Our results revealed that HPCa did not express the ES cell-specific Nanog1 mRNA but primarily expressed NanogP8 together with several other Nanog pseudogenes including NanogP7 and NanogP6. Interestingly, most HPCa specimens contained multiple isoforms of NanogP8 transcripts, and we identified novel missense mutations in the NanogP8 transcripts that could lead to amino acid changes. Experiments with recombinant proteins, site-directed mutagenesis and Western blotting revealed several mutations that conferred the NanogP8 variant proteins, including NanogP8L61P, NanogP8D64Y, and NanogP8N130S, with unique biochemical properties. Moreover, some mutations furnish NanogP8 isoforms with distinct CSC and oncogenic characteristics. Altogether, this study advances our knowledge of the molecular, biochemical and oncogenic properties of Nanog expression and NanogP8 isoforms in PCa.

Cancer biology

What the data shows

  • No database records a citation yet, as is usual for a paper this new.
  • Dean G. Tang has the highest h-index among the authors (71).

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (13)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (0)

What it cites, from open citation data, with Crossref's record of each.

No references in the open citation data yet.
Multiple isoforms of cancer stemness regulator NanogP8 in clinical prostate cancer specimens and their unique biochemical and oncogenic properties - QAI OpenResearch